Vivici set to launch second protein ingredient later this year.
Fonterra- and DSM-backed Dutch ingredients startup company Vivici says it has secured €32.5 million ($58.89m) in funding, which it will use to turn its precision fermentation technology into commercial reality.
The funding was led by APG on behalf of ABP, one of the largest pension funds in the world, and Invest-NL. Others included InnovationQuarter, as well as continued support from existing shareholders DSM-Firmenich and Fonterra.
The funding will be used to expand its access into new international markets, launch a second dairy protein ingredient and establish long-term manufacturing capabilities.
Isolated whey protein Vivitein BLG is the first ingredient to be launched under the company’s Vivitein protein platform.
“With our Vivitein protein platform, we’re bringing a new standard of protein to the market – one that will become a mainstay of consumer protein products.”
Vivitein BLG targets consumers in the active nutrition category. The category was valued globally at US$28.4 billion ($49.63m) a year in 2023 and grew by 8.5% in that year , with similar growth expected for coming years.
Its second ingredient, lactoferrin – Vivitein LF – is to be launched later this year.
You can now read the most important #news on #eDairyNews #Whatsapp channels!!!
🇺🇸 eDairy News INGLÊS: https://whatsapp.com/channel/0029VaKsjzGDTkJyIN6hcP1K
